ArticleTranslational cancer research2025
Multi-omics analysis reveals intratumoral microbiota as modulators of the immune environment within thyroid cancer.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Crosstalk between the microbiome and immune microenvironment in the pathogenesis and treatment of thyroid carcinoma: a narrative review.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recent studies indicate that intratumoral microbiota play a crucial role in tumor development. While research on microbiota and thyroid cancer (TC) has primarily focused on gut microbiota, studies on intratumoral microbiota are limited. This study utilizes multi-omics analysis to investigate the effects and mechanisms of intratumoral microbiota on TC. Methods: We analyzed the microbial profile in the TC tumor microenvironment using data from published The Cancer Genome Atlas (TCGA) program. The impact of microbes on TC signaling pathways and the immune environment was examined through a combined analysis of the microbiome, transcriptome, and immune infiltration. Results: Significant differences in microbial diversity were observed between TC tumor tissue and adjacent non-tumor tissue. Specifically, there were notable differences in the relative abundance of 12 microbial species at the genus level. Additionally, there were marked differences in the infiltration scores of 11 immune cell species in the tumor microenvironment compared to adjacent tissues. Nine of these immune cell species were correlated with eight differentially expressed genes, and these genes were associated with differential bacterial abundance at the genus level. Conclusions: Our findings reveal that the diversity and relative abundance of intratumoral microbiota are associated with tumorigenesis in TC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.